DexCom Stock Forward View - Simple Regression
| DXCM Stock | USD 67.81 -0.93 -1.35% |
Momentum 44
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.78 | EPS Estimate Next Quarter 0.4762 | EPS Estimate Current Year 2.4974 | EPS Estimate Next Year 2.9887 | Wall Street Target Price 85.8462 |
This section relates DexCom Inc headline activity to recent price behavior and peer context. Options positioning and short interest are used here to outline sentiment for DexCom.
DexCom Short Interest Summary
DexCom's short interest measures the total number of shares sold short but not yet covered. Rising short interest can signal growing bearish sentiment among institutional and retail investors.
200 Day MA 73.4985 | Short Percent 0.0489 | Short Ratio 2.38 | Shares Short Prior Month 15.5 M | 50 Day MA 70.6072 |
DexCom RSI Snapshot
The Simple Regression forecasted value of DexCom Inc on the next trading day is expected to be 72.83 with a mean absolute deviation of 1.73 and the sum of the absolute errors of 105.67.DexCom Inc Hype vs Price Pattern
Public perception of DexCom Inc - captured through news and social media signals - can drive DexCom's stock price away from intrinsic value for extended periods. Analyzing these biases provides an edge for contrarian investors.
When DexCom's market sentiment is overly bullish relative to its actual financial performance, the stock may be overvalued. Excessively negative sentiment can create buying opportunities for patient investors.
DexCom Implied Volatility | 0.81 |
High implied volatility in DexCom's options signals that the market anticipates large price swings in DexCom stock. Conversely, low implied volatility indicates that investors expect relatively stable price action.
The Simple Regression forecasted value of DexCom Inc on the next trading day is expected to be 72.83 with a mean absolute deviation of 1.73 and the sum of the absolute errors of 105.67.DexCom after-hype prediction price | USD 68.7 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of DexCom to cross-verify projections for DexCom. The historical view provides additional context.Rule 16 for the current DexCom contract - Pricing Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0506% for the 2026-03-20 options. This estimate is a volatility reference; at USD 67.81, it implies a move of about USD 0.0343 per day.
DexCom Options Open Interest - 2026-03-20
Open interest on DexCom summarizes how many option contracts remain open and helps frame liquidity and positioning.
DexCom Additional Predictive Modules
Most predictive techniques to examine DexCom price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DexCom using various technical indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
DexCom Simple Regression Price Forecast For the 11th of March 2026
Given 90 days horizon, the Simple Regression forecasted value of DexCom Inc on the next trading day is expected to be 72.83 with a mean absolute deviation of 1.73 , mean absolute percentage error of 4.58 , and the sum of the absolute errors of 105.67 .Please note that although there have been many attempts to predict DexCom Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that DexCom's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
DexCom Stock Forecast Pattern
| Backtest DexCom | DexCom Price Prediction | Research Analysis |
DexCom Forecasted Value
This next-day forecast for DexCom Inc uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of DexCom stock data series using in forecasting. Note that when a statistical model is used to represent DexCom stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.6313 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.7324 |
| MAPE | Mean absolute percentage error | 0.0248 |
| SAE | Sum of the absolute errors | 105.6746 |
The concept of mean reversion suggests that DexCom's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
DexCom After-Hype Price Density Analysis
The price distribution graph for DexCom visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of DexCom's outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
DexCom Estimiated After-Hype Price Volatility
The downside and upside margins for DexCom after major news events are estimated from historical precedent. DexCom's after-hype downside and upside margins for the prediction period are 66.73 and 70.67, respectively. This approach captures the empirical distribution of DexCom's short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to DexCom Inc assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
DexCom Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as DexCom is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DexCom backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DexCom, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 1.96 | 0.01 | 0.12 | 9 Events | 8 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
67.81 | 68.70 | 0.06 |
|
DexCom Hype Timeline
DexCom Inc is currently traded for 67.81. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.12. DexCom is forecasted to decline in value after the next headline, with the price expected to drop to 68.7. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.06%, whereas the daily expected return is currently at 0.05%. The volatility of related hype on DexCom is about 80.92%, with the expected price after the next announcement by competition of 67.93. About 100.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.01. DexCom Inc had not issued any dividends in recent years. The entity completed a 4:1 stock split on 13th of June 2022. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Use Historical Fundamental Analysis of DexCom to cross-verify projections for DexCom. The historical view provides additional context.DexCom Related Hype Analysis
The relationship between DexCom and its sector peers means that news affecting one company often reverberates across DexCom's competitive landscape. Tracking peer hype helps investors anticipate DexCom's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STE | STERIS plc | 3.16 | 10 per month | 0.00 | -0.12 | 1.69 | -2.68 | 10.43 | |
| PODD | Insulet | 3.53 | 9 per month | 0.00 | -0.22 | 2.79 | -3.48 | 8.24 | |
| ZBH | Zimmer Biomet Holdings | 0.77 | 9 per month | 1.37 | -0.0046 | 2.22 | -2.27 | 7.13 | |
| PHG | Koninklijke Philips NV | 0.13 | 8 per month | 1.88 | 0.02 | 2.43 | -2.63 | 15.21 | |
| SNN | Smith Nephew SNATS | 0.14 | 8 per month | 1.69 | 0.05 | 2.29 | -1.94 | 7.58 | |
| LH | Laboratory of | -0.61 | 9 per month | 1.37 | 0.01 | 2.63 | -2.11 | 7.89 | |
| WAT | Waters | 6.30 | 14 per month | 0.00 | -0.18 | 2.32 | -2.85 | 17.35 | |
| BIIB | Biogen Inc | 4.54 | 11 per month | 1.82 | 0.03 | 4.38 | -2.84 | 12.20 | |
| WST | West Pharmaceutical Services | 5.90 | 9 per month | 0.00 | -0.07 | 2.76 | -3.58 | 11.15 | |
| TEVA | Teva Pharma Industries | 0.36 | 9 per month | 1.30 | 0.14 | 3.53 | -2.20 | 8.75 |
Other Forecasting Options for DexCom
Whether a novice or experienced investor, anyone considering DexCom needs to understand the dynamics of DexCom's price movement. Price charts for DexCom Stock contain a significant amount of noise that can distort investment decisions.DexCom Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DexCom stock to make a market-neutral strategy. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
DexCom Market Strength Events
Analyzing market strength indicators for DexCom enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in DexCom Inc.
DexCom Risk Indicators
Identifying and analyzing DexCom's key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with DexCom's and decide how to manage it.
| Mean Deviation | 1.32 | |||
| Semi Deviation | 1.65 | |||
| Standard Deviation | 1.9 | |||
| Variance | 3.62 | |||
| Downside Variance | 3.14 | |||
| Semi Variance | 2.71 | |||
| Expected Short fall | -1.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for DexCom
Coverage intensity for DexCom Inc matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
DexCom Short Properties
Short sentiment tied to DexCom Inc matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 405.5 M | |
| Cash And Short Term Investments | 2 B |
More Resources for DexCom Stock Analysis
A structured review of DexCom Inc often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Dexcom Inc Stock in context:Use Historical Fundamental Analysis of DexCom to cross-verify projections for DexCom. The historical view provides additional context. Analysis related to DexCom should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Quarterly Earnings Growth 0.78 | Earnings Share 2.09 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets |
The market value of DexCom Inc is measured differently than book value, which reflects DexCom accounting equity. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Market price responds to sentiment, liquidity, and macro shifts, so gaps can appear. Valuation work aligns these measures into a single context.
Note that DexCom's intrinsic value and market price are different measures derived from different inputs. Context can include financial performance, operating efficiency, market trends, and peer comparisons. Trading price represents the transaction level agreed by market participants.